NIKKEI 225
38,708.39 -211.87 (-0.54%) HANG SENG
19,525.12 +148.59 (+0.77%) CRUDE OIL
79.23 0.00 (0.00%) GOLD FUTURES
2,380.90 -4.60 (-0.19%) DOW
39,869.38 -38.62 (-0.10%) Bitcoin GBP
51,627.54 -504.70 (-0.97%)
SRRK Oct 2024 20.000 call
| Previous close | 1.0600 |
| Open | 1.7500 |
| Bid | 1.7000 |
| Ask | 2.5000 |
| Strike | 20.00 |
| Expiry date | 2024-10-18 |
| Day's range | 1.0500 - 1.7500 |
| Contract range | N/A |
| Volume | |
| Open interest | 42 |
Business WireScholar Rock to Host Investor Day on May 22, 2024
CAMBRIDGE, Mass., May 14, 2024--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced it will host an Investor Day on Wednesday, May 22, 2024 beginning at 8:30 a.m. ET in New York City.
- GuruFocus.com
Scholar Rock Holding Corp (SRRK) Reports Q1 2024 Financial Results: A Detailed Analysis
Exploring the Financial Landscape and Strategic Progress Amidst Challenges
Business WireScholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress
CAMBRIDGE, Mass., May 07, 2024--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today reported financial results and corporate updates for the first quarter ended March 31, 2024.
